AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial
Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme
The two-dose regimen for ZyCoV-D was tested in 3100 healthy volunteers more than 12 years of age
The commitment is expected to generate over 5.56 lakh jobs and positively impact the lives of more than 76 lakh people, the ministry said
The first use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Subscribe To Our Newsletter & Stay Updated
